ArticleJournal of cellular and molecular medicine2019

Prolyl oligopeptidase inhibition reduces PolyQ aggregation and improves cell viability in cellular model of Huntington's disease.

Susanna Norrbacka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.